文献速递消化内镜消化道肿瘤与早癌

结直肠内镜黏膜下剥离术后局部复发:大型国际西方多中心研究

Local recurrence after colorectal endoscopic submucosal dissection: a large international Western multicenter study.
PubMed 文献 · Gastrointest Endosc · 2026-07-06

该多中心回顾性研究纳入2015至2025年13个中心2182例结直肠ESD患者,中位病变34mm,整块切除率93.6%、R0切除率81.1%。1478例有监测结肠镜数据,局部复发率1.5%(22/1478),中位14个月;极低风险病变(<40mm且仅低级别异型增生)复发率0.8%(4/478)。严重纤维化为复发危险因素(OR 2.40),R0切除与较低复发相关(OR 0.30)。

要点

  • 结直肠ESD后局部复发率1.5%,极低风险病变仅0.8%。
  • 严重黏膜下纤维化与局部复发独立相关(OR 2.40)。
  • R0切除与较低局部复发风险相关(OR 0.30)。

核心结论

  • 在非亚洲多中心队列中,结直肠ESD后局部复发率为1.5%,极低风险病变为0.8%。
  • 严重黏膜下纤维化和R1/Rx切除与局部复发独立相关。
  • 数据支持ESD后12个月监测结肠镜的现行推荐,并提示极低风险病变可延长间隔。

研究设计与样本

  • 回顾性分析2015年1月至2025年9月13个中心的结直肠ESD病例。
  • 共2182例患者,中位病变大小34mm。
  • 局部复发定义为监测结肠镜在ESD部位发现的肿瘤。
  • 按类别1至4分层计算复发风险,并行多因素logistic回归分析复发相关因素。

主要发现

  • 整块切除率93.6%,R0切除率81.1%。
  • 1478例有监测结肠镜数据,局部复发率1.5%(22/1478),中位14个月。
  • 类别1复发率1.5%(12/775),类别2为0.9%(3/330),类别3为2.2%(6/279),类别4为1.1%(1/94)。
  • 极低风险病变(<40mm且组织学仅低级别异型增生)复发率0.8%(4/478)。
  • 严重纤维化为局部复发危险因素(OR 2.40;95%CI 1.12-4.89;P=.019),R0切除与较低复发相关(OR 0.30;95%CI 0.15-0.58;P<.001)。

关键数值与推荐

  • 类别1:低级别异型增生R0切除;类别2:高级别异型增生R0切除。
  • 类别3:非浸润性肿瘤R1/Rx切除;类别4:T1a癌治愈性切除。
  • 极低风险病变定义:大小<40mm且组织学仅低级别异型增生。

临床怎么用

  • 结直肠ESD后应按现行推荐在12个月行监测结肠镜。
  • 对极低风险病变可考虑延长监测间隔。
  • 严重黏膜下纤维化或R1/Rx切除患者应加强复发监测。

局限性

  • 回顾性设计。
  • 仅1478/2182例患者有监测结肠镜数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Western data to help guide surveillance recommendations after colorectal endoscopic submucosal dissection (ESD) remain scarce. In this multicenter study, we evaluate and stratify the risk of local recurrence after colorectal ESD. METHODS: A retrospective analysis of colorectal ESD at 13 centers was conducted between January 2015 and September 2025. Local recurrence was defined as neoplasia at the ESD site detected during surveillance colonoscopy (SC). Recurrence risk was calculated for the following groups: category 1 (R0 resection of low-grade dysplasia [LGD]), category 2 (R0 resection of high-grade dysplasia), category 3 (R1/Rx resection of noninvasive neoplasia), and category 4 (curative resection of T1a cancer). Multivariable logistic regression was performed to identify factors associated with recurrence. RESULTS: In total, 2182 patients underwent colorectal ESD (median lesion size of 34 mm). En bloc and R0 resection rates were 93.6% and 81.1%, respectively. SC data were available in 1478 of the 2182 patients. Local recurrence occurred in 1.5% (22/1478) of patients at a median of 14 months: 1.5% (12/775) in category 1, 0.9% (3/330) in category 2, 2.2% (6/279) in category 3, and 1.1% (1/94) in category 4. Recurrence in very-low-risk lesions (defined as <40 mm in size with only LGD on histology) was 0.8% (4/478). Severe fibrosis was a risk factor for local recurrence (OR, 2.40; 95% CI, 1.12-4.89; P = .019), whereas R0 resection was associated with a lower likelihood (OR, 0.30; 95% CI, 0.15-0.58; P < .001). CONCLUSIONS: In this multicenter non-Asian study, local recurrence after colorectal ESD was 1.5% and 0.8% for very-low-risk lesions. Severe submucosal fibrosis and R1/Rx resection were independently associated with local recurrence. Our data support current recommendations for SC at 12 months after ESD and raise the possibility of a longer interval for very-low-risk lesions.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bani Fawwaz BA, Stavropoulos SN, Zhang Y, et al. Local recurrence after colorectal endoscopic submucosal dissection: a large international Western multicenter study. Gastrointest Endosc. 2026. PMID: 42409295. doi:10.1016/j.gie.2026.06.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。